Business · 15/08/2016
FDA Hosts Public Workshop to Discuss Anti-Infective Drug Development for Neonates and Young Infants
The US Food and Drug Administration (FDA) is hosting a public workshop to gather input from healthcare providers, government agencies, and industry experts on the challenges of developing anti-infective drugs for newborns and young infants.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →